A new study reveals that Pfizer-Biontech's MRNA based coronavirus vaccine produces 10 times more antibodies than the virus based vaccine made by China's Sinovac. This study only adds to the growing body of research that suggests that vaccines using MRNA technology offer stronger protection against the virus as opposed to typical methods. Dr. Asha Shah, Director of Infectious Diseases & Hospital Epidemiologist, Stamford Health joined Cheddar's 'Search for a Cure: COVID-19' for more.